Castration Resistance | List of Frontiers open access articles

Original Research

Published on 07 Jan 2021

The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA Sequencing

in Molecular and Cellular Oncology

Tianyu Guo
Yang Wang
Jing Jia
Xueying Mao
Elzbieta Stankiewicz
Glenda Scandura
Edwina Burke
Lei Xu
Jacek Marzec
Caitlin R. Davies

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2020.602493

8,703 views
62 citations

Review

Published on 03 Jun 2024

Molecular landscape for risk prediction and personalized therapeutics of castration-resistant prostate cancer: at a glance

in Cancer Endocrinology

Jingang Jian
Xin’an Wang
Jun Zhang
Chenchao Zhou
Xiaorui Hou
Yuhua Huang
Jianquan Hou
Yuxin Lin
Xuedong Wei

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1360430

4,152 views
2 citations

Original Research

Published on 02 Aug 2019

Gene Expression Profiling Analysis Reveals Putative Phytochemotherapeutic Target for Castration-Resistant Prostate Cancer

in Genitourinary Oncology

Solomon Oladapo Rotimi
Oluwakemi Anuoluwapo Rotimi
Abdulkadir Ayo Salako
Paul Jibrin
Jelili Oyelade
Emeka E. J. Iweala

Frontiers in Oncology

doi 10.3389/fonc.2019.00714

7,212 views
14 citations

Original Research

Published on 14 Oct 2022

Anti-prostate cancer metabolites from the soil-derived Aspergillus neoniveus

in Pharmacology of Anti-Cancer Drugs

Menna Fayek
Hassan Y. Ebrahim
Heba E. Elsayed
Mohamed S. Abdel-Aziz
Benson M. Kariuki
Fatma A. Moharram

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1006062

4,698 views
8 citations

Original Research

Published on 07 Aug 2020

Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling

in Pharmacology of Anti-Cancer Drugs

Jui-Ling Hsu
Wohn-Jenn Leu
Lih-Ching Hsu
Chen-Hsun Ho
Shih-Ping Liu
Jih-Hwa Guh

Frontiers in Oncology

doi 10.3389/fonc.2020.01274

6,760 views
24 citations

Original Research

Published on 07 May 2021

Combined Anti-Cancer Effects of Platycodin D and Sorafenib on Androgen-Independent and PTEN-Deficient Prostate Cancer

in Cancer Molecular Targets and Therapeutics

Zongliang Lu
Wei Song
Yaowen Zhang
Changpeng Wu
Mingxing Zhu
He Wang
Na Li
Yong Zhou
Hongxia Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.648985

4,402 views
18 citations

Original Research

Published on 16 Mar 2021

Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical Parameters

in Cancer Molecular Targets and Therapeutics

Evgeniya Sharova
Marco Maruzzo
Paola Del Bianco
Ilaria Cavallari
Francesco Pierantoni
Umberto Basso
Vincenzo Ciminale
Vittorina Zagonel

Frontiers in Oncology

doi 10.3389/fonc.2021.626104

3,877 views
9 citations

Articles

The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA Sequencing

Molecular landscape for risk prediction and personalized therapeutics of castration-resistant prostate cancer: at a glance

Gene Expression Profiling Analysis Reveals Putative Phytochemotherapeutic Target for Castration-Resistant Prostate Cancer

Anti-prostate cancer metabolites from the soil-derived Aspergillus neoniveus

Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling

Combined Anti-Cancer Effects of Platycodin D and Sorafenib on Androgen-Independent and PTEN-Deficient Prostate Cancer

Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical Parameters